Donald Calne

Last updated
Donald Calne
Born (1936-05-04) May 4, 1936 (age 88)
London, England
CitizenshipCanadian
Alma mater University of Oxford
Awards Killam Research Prize,
Starr Award, Officer of the Order of Canada, fellow of the Royal Society of Canada, Hon degree UBC
Scientific career
Fields Neurology
Institutions Retired Professor Emeritus

Donald Brian Calne, OC FRSC (born May 4, 1936), is a Canadian neurologist who is a leading Parkinson's disease researcher. [1] [2] [3]

Contents

Biography

Born in London, England, he received his Bachelor of Arts, Bachelor of Science and Doctor of Medicine degrees from the University of Oxford.[ citation needed ] He worked in England and at the National Institute of Health in Bethesda, Maryland until 1980. [4] From 1981 to 2001, he was the Director of the Neurodegenerative Disorders Centre at the University of British Columbia and a professor of neurology.[ citation needed ] He is a member of the National Parkinson Foundation's Scientific Advisory Board. [5] [6]

In 1998, he was made an Officer of the Order of Canada. In 2001, he was made a Fellow of the Royal Society of Canada. [7] [8] In 2002, he received an Honorary Doctor of Science degree from the University of British Columbia. [4] He was a member of the Steering Committee of the 1st World Parkinson Congress (WPC) in 2006. [9]

He was the first researcher to use L dopa in the UK and the first to show how to use synthetic dopamine to treat Parkinson's disease. He has shown that latent damage occurs in the brain even before the symptoms of Parkinson's disease appears. [4] [10] [11]

In 1999, he published the book, Within Reason: Rationality and Human Behavior. [12] [13] [14] [15]

He married Susan M. Wigfield, who has been a nurse and co-ordinator at the UBC hospital’s movement disorders clinic. They worked with people with Parkinson's disease together for 25 years. [16] [17] [18]

See also

Related Research Articles

<span class="mw-page-title-main">University of British Columbia</span> Public university in Canada

The University of British Columbia (UBC) is a public research university with campuses near Vancouver and Okanagan, in British Columbia, Canada. Established in 1908, it is the oldest university in British Columbia. With an annual research budget of $747.3 million, UBC funds 9,675 projects annually in various fields of study within the industrial sector, as well as governmental and non-governmental organizations.

<span class="mw-page-title-main">Michael Smith (chemist)</span> British-born Canadian biochemist, businessman and Nobel Prize laureate (1932–2000)

Michael Smith was a British-born Canadian biochemist and businessman. He shared the 1993 Nobel Prize in Chemistry with Kary Mullis for his work in developing site-directed mutagenesis. Following a PhD in 1956 from the University of Manchester, he undertook postdoctoral research with Har Gobind Khorana at the British Columbia Research Council in Vancouver, British Columbia, Canada. Subsequently, Smith worked at the Fisheries Research Board of Canada Laboratory in Vancouver before being appointed a professor of biochemistry in the UBC Faculty of Medicine in 1966. Smith's career included roles as the founding director of the UBC Biotechnology Laboratory and the founding scientific leader of the Protein Engineering Network of Centres of Excellence (PENCE). In 1996 he was named Peter Wall Distinguished Professor of Biotechnology. Subsequently, he became the founding director of the Genome Sequencing Centre at the BC Cancer Research Centre.

Douglas Harold Copp was a Canadian scientist who discovered and named the hormone calcitonin, which is used in the treatment of bone disease.

<span class="mw-page-title-main">UBC Sauder School of Business</span>

The UBC Sauder School of Business is the business school of the University of British Columbia. The faculty is located in Vancouver on UBC's Point Grey campus and has a secondary teaching facility at UBC Robson Square downtown. UBC Sauder has been accredited by AACSB since 2003. The current Dean is Darren Dahl.

J. William Langston is the founder and chief scientific officer, movement disorder specialist, and chief executive officer of the Parkinson's Institute and Clinical Center in Sunnyvale, California, the founding member of the Scientific Advisory Board for the Michael J. Fox Foundation and the Co-Editor-in-Chief of the Journal of Parkinson's Disease. He is a graduate of the University of Missouri School of Medicine. Langston was formerly a faculty member at Stanford University and Chairman of Neurology at Santa Clara Valley Medical Center in San Jose, California. Langston has authored or co-authored some 360 peer-reviewed articles in the field of neurology, most of which are on Parkinson's disease and related disorders. Langston gained national and international recognition in 1982 for the discovery of the link between a "synthetic heroin" contaminant (MPTP) and parkinsonism.

<span class="mw-page-title-main">Vancouver Hospital and Health Sciences Centre</span> Hospital in British Columbia, Canada

Vancouver Hospital and Health Sciences Centre (VHHSC) is an acute care hospital affiliated with the University of British Columbia and located in Vancouver, British Columbia. The VHHSC is the second largest hospital in Canada, with 1,900 beds and nearly 116,000 patients each year. VHHSC employs 9500 staff and utilizes 1000 volunteers. As of 2005, the hospital's annual budget is $463 million. It is managed by Vancouver Coastal Health.

Enrico Fazzini is an American neurologist. He is considered an expert on Parkinson's disease and has published numerous research publications on the subject. He has been involved in a number of clinical trials for new pharmaceutical treatments for Parkinson's disease. He attended the University of Osteopathic Medicine and Health Sciences in Des Moines, Iowa. He is board certified in neurology by both the M.D. and D.O. medical boards. He began his practice in 1989. Dr. Enrico Fazzini completed his neurology training at Boston University in 1987 and his fellowship in Movement Disorders at Columbia Presbyterian in 1989. In addition to being a neurologist, Fazzini has a Ph.D. in Behavioral Neuroscience from Boston University and is an expert on the diagnosis and treatment of patients with traumatic brain injuries.

Juhn Atsushi Wada was a Japanese–Canadian neurologist known for research into epilepsy and human brain asymmetry, including his description of the Wada test for cerebral hemispheric dominance of language function. The Wada Test remains the gold standard for establishing cerebral dominance and is conducted worldwide prior to epilepsy surgery.

<span class="mw-page-title-main">James McEwen (engineer)</span> Canadian biomedical engineer

James McEwen is a Canadian biomedical engineer and the inventor of the microprocessor-controlled automatic tourniquet system, which is now standard for 15,000-20,000 procedures daily in operating rooms worldwide. Their widespread adoption and use has significantly improved surgical safety, quality and economy. McEwen is President of Western Clinical Engineering Ltd., a biomedical engineering research and development company and he is a director of Delfi Medical Innovations Inc., a company he founded to commercialize some results of that research and development. He is also an adjunct professor in the School of Biomedical Engineering, in the Department of Orthopaedics and in the Department of Electrical and Computer Engineering at the University of British Columbia.

<span class="mw-page-title-main">Andrew Lees (neurologist)</span> UK neurologist (born 1947)

Andrew John Lees FRCP FRCP(G) FMedSci is Professor of Neurology at the National Hospital for Neurology and Neurosurgery, Queen Square, London and University College London. In 2011 he was named as the world's most highly cited Parkinson's disease researcher.

Patricia Ann Baird, is a British medical geneticist active in Canada. Her research has specialized on the relationship between medical technology and ethics.

<span class="mw-page-title-main">Joseph Jankovic</span> American neurologist

Joseph Jankovic is an American neurologist and professor at Baylor College of Medicine in Houston, Texas. He is the Distinguished Chair in Movement Disorders and founder and director of the Parkinson's Disease Center and Movement Disorders Clinic.

<span class="mw-page-title-main">Michael R. Hayden</span>

Michael R. Hayden, is a Killam Professor of Medical Genetics at the University of British Columbia, the highest honour UBC can confer on any faculty member. Only four such awards have ever been conferred in the Faculty of Medicine. Dr. Hayden is also Canada Research Chair in Human Genetics and Molecular Medicine. Hayden is best known for his research in Huntington disease (HD).

Aubrey Tingle is professor emeritus in the Department of Pediatrics at the University of British Columbia (UBC) and chair of the board of directors at the Maternal, Infant, Child and Youth Research Network. In March 2001, Tingle was appointed the first president and CEO of The Michael Smith Foundation for Health Research (MSFHR).

<span class="mw-page-title-main">Alim Louis Benabid</span>

Alim Louis Benabid is a French-Algerian emeritus professor, neurosurgeon and member of the French Academy of Sciences, who has had a global impact in the development of deep brain stimulation (DBS) for Parkinson's disease and other movement disorders. He became emeritus professor of biophysics at the Joseph Fourier University in Grenoble in September 2007, and chairman of the board of the Edmond J. Safra Biomedical Research Center in 2009 at Clinatec, a multidisciplinary institute he co-founded in Grenoble that applies nanotechnologies to neurosciences.

Alexander Jon Stoessl is a Canadian neurologist and Parkinson's disease researcher. He is the director of the Pacific Parkinson's Research Centre and Parkinson's Foundation Centre of Excellence at the University of British Columbia (UBC). He is also the head of the division of neurology at this university. He is currently the President of the World Parkinson Coalition.

B. Brett Finlay, is a Canadian microbiologist well known for his contributions to understanding how microbes cause disease in people and developing new tools for fighting infections, as well as the role the microbiota plays in human health and disease. Science.ca describes him as one of the world's foremost experts on the molecular understanding of the ways bacteria infect their hosts. He also led the SARS Accelerated Vaccine Initiative (SAVI) and developed vaccines to SARS and a bovine vaccine to E. coli O157:H7. His current research interests focus on pathogenic E. coli and Salmonella pathogenicity, and the role of the microbiota in infections, asthma, and malnutrition. He is currently the UBC Peter Wall Distinguished Professor and a Professor in the Michael Smith Laboratories, Microbiology and Immunology, and Biochemistry and Molecular Biology, and Co-director and Senior Fellow for the CIFAR Humans and Microbes program. He is also co-author of the book Let Them Eat Dirt: Saving Your Child from an Oversanitized World and The Whole-Body Microbiome: How to Harness Microbes - Inside and Out - For Lifelong Health. Finlay is the author of over 500 publications in peer-reviewed journals and served as editor of several professional publications for many years.

Janice Jennifer Eng is a professor in the University of British Columbia's Department of Physical Therapy and Canada Research Chair in Neurological Rehabilitation.

Howard H Feldman is a professor of neurosciences at the University of California, San Diego (UCSD). He was appointed director of the Alzheimer's Disease Cooperative Study (ADCS) in April 2016. Prior to joining UCSD, he served as the Executive Associate Dean for Research, Faculty of Medicine, University of British Columbia (UBC) and was the director of the Alzheimer's and Related Disorders Clinic at UBC.

Andres M. Lozano is a Spanish-Canadian neurosurgeon and scientist known for his work in Deep Brain Stimulation and MR guided Focused Ultrasound Surgery. He holds the Alan & Susan Hudson Cornerstone Chair in Neurosurgery at the University Health Network Toronto and is a University Professor at the University of Toronto. His scientific discoveries have been covered by major international news publications including BBC, Scientific American, The Independent, The Globe and Mail and NPR.

References

  1. ↑ "Donald Calne | Penguin Random House". PenguinRandomhouse.com.
  2. ↑ "Donald Calne". www.librarything.com. Retrieved 2019-09-20.
  3. ↑ "Error". Archived from the original on 2016-03-06. Retrieved 2009-11-23.
  4. 1 2 3 "UBC Archives - Honorary Degree Citations - 2000-02". www.library.ubc.ca.
  5. ↑ "2008 Donald Calne Lectureship | Faculty of Medicine | University of Calgary". Archived from the original on 2011-07-06. Retrieved 2009-10-30.
  6. ↑ [ permanent dead link ]
  7. ↑ "Dr. D.B. Calne". Archived from the original on 2011-07-06. Retrieved 2009-11-23.
  8. ↑ "PacificParkinsons.org > Expert Resources". Archived from the original on 2008-08-27. Retrieved 2009-11-23.
  9. ↑ "WPC :: WPC 2006 Featured Speakers". Archived from the original on 2011-08-27. Retrieved 2009-11-23.
  10. ↑ "Progress In The Treatment Of Parkinsonism". www.goodreads.com.
  11. ↑ http://www.bcic.ca/recognition/awards/past-recipients/previous-recipients/427-health-sciences%5B%5D
  12. ↑ Calne, Donald B. (1999). Within Reason: Rationality and Human Behavior. New York, Pantheon Books. ISBN   978-0-375-40351-4.
  13. ↑ "Author: Donald B. Calne, M.D." Archived from the original on 2007-02-23. Retrieved 2009-10-30.
  14. ↑ "PowWeb". www.human-nature.com. Retrieved 2019-09-20.
  15. ↑ "Metapsychology Online Reviews". metapsychology.mentalhelp.net. Retrieved 2019-09-20.
  16. ↑ Parkinson's Disease a Mystery at The Canadian Encyclopedia
  17. ↑ [ dead link ]
  18. ↑ [ permanent dead link ]
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.